Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? a historical and contemporary view

Schizophrenia Bulletin

Volumn 39, Issue 2, 2013, Pages 266-267

  Fernandez Egea, Emilio ^a   Garcia Rizo, Clemente ^b   Zimbron, Jorge ^a   Kirkpatrick, Brian ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HOSPITAL CLÍNIC   (Spain)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NEUROLEPTIC AGENT;

AGING; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HEALTH CARE ACCESS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MENTAL PATIENT; META ANALYSIS; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONAFFECTIVE PSYCHOSIS; NOTE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; SCHIZOPHRENIA;

EID: 84874514805     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs134     Document Type: Note

References (9)

1. Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia A comparative meta-analysis of first episode, untreated and treated patients [published online ahead of print August 27, 2012]. Schizophr Bull. doi:10.1093/schbul/sbs082
2. Lorenz WF. Sugar tolerance in dementia praecox and other mental disorders. Arch Neurol Psychiatry. 1922;8:184-196.
3. Cohn TA, Remington G, Zipursky RB, Azad A, Connolly P, Wolever TM. Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report. Can J Psychiatry. 2006;51:382-386. (Pubitemid 43854472)
4. Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabet Med. 2007;24:481-485. (Pubitemid 46669314)
5. Saddichha S, Manjunatha N, Ameen S, Akhtar S. Diabetes and schizophrenia-effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. Acta Psychiatr Scand. 2008;117:342-347. (Pubitemid 351502438)
6. Sengupta S, Parrilla-Escobar MA, Klink R, et al. Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res. 2008;102:329-336.
7. Fernandez-Egea E, Bernardo M, Donner T, et al. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry. 2009;194:434-438.
8. Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging? Schizophr Bull. 2008;34:1024-1032.
9. Kirkpatrick B, Miller BJ, Garcia-Rizo C, Fernandez-Egea E, Bernardo M. Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits? Schizophr Bull. 2012;38:280-284.